informing the capacitation of clinic committees in high hiv prevalence areas
DESCRIPTION
TRANSCRIPT
![Page 1: Informing the Capacitation of Clinic Committees in High HIV prevalence Areas](https://reader036.vdocument.in/reader036/viewer/2022062616/549c773cb47959aa318b4723/html5/thumbnails/1.jpg)
Informing the Capacitation of Clinic Committees in High Prevalence Areas
R Rapiti, N Nkhwashu, R Maithufi, F Cleghorn and M Madibane
in collaboration with the
South African National Department of Health
PHASA 2012
Bloemfontein, South Africa
![Page 2: Informing the Capacitation of Clinic Committees in High HIV prevalence Areas](https://reader036.vdocument.in/reader036/viewer/2022062616/549c773cb47959aa318b4723/html5/thumbnails/2.jpg)
Background
• USAID Sexual HIV Prevention Programme (SHIPP);
• HIV Combination Prevention;
• Multi- sector approach : health, education and social;
• Capacity building and deliver technical assistance;
• Provision of short-and medium-term technical assistance;
• Strengthen coordination of efforts at the local level.
Slide 2
![Page 3: Informing the Capacitation of Clinic Committees in High HIV prevalence Areas](https://reader036.vdocument.in/reader036/viewer/2022062616/549c773cb47959aa318b4723/html5/thumbnails/3.jpg)
Geographic Focus Slide 3
![Page 4: Informing the Capacitation of Clinic Committees in High HIV prevalence Areas](https://reader036.vdocument.in/reader036/viewer/2022062616/549c773cb47959aa318b4723/html5/thumbnails/4.jpg)
SHIPP’s Objectives
Slide 4
1. Strengthen leadership capacity of SAG departments
2. Strengthen HIV prevention service delivery
systems 3. Improve the quality, effectiveness and
coverage of HIV prevention programmes
![Page 5: Informing the Capacitation of Clinic Committees in High HIV prevalence Areas](https://reader036.vdocument.in/reader036/viewer/2022062616/549c773cb47959aa318b4723/html5/thumbnails/5.jpg)
AIM • Series of health capacitation activities at the district
level;
• Using a Baseline Evaluation to Inform the Capacitation of Clinic Committees in High Prevalence Areas of Gauteng, KwaZulu-Natal and Mpumalanga Provinces
Slide 5
![Page 6: Informing the Capacitation of Clinic Committees in High HIV prevalence Areas](https://reader036.vdocument.in/reader036/viewer/2022062616/549c773cb47959aa318b4723/html5/thumbnails/6.jpg)
Transfer of skills
Slide 8
Sustainable Best
Practices
Share/
Apply Evaluate
![Page 7: Informing the Capacitation of Clinic Committees in High HIV prevalence Areas](https://reader036.vdocument.in/reader036/viewer/2022062616/549c773cb47959aa318b4723/html5/thumbnails/7.jpg)
A Balancing Act
Slide 9
![Page 8: Informing the Capacitation of Clinic Committees in High HIV prevalence Areas](https://reader036.vdocument.in/reader036/viewer/2022062616/549c773cb47959aa318b4723/html5/thumbnails/8.jpg)
Method
• 13 Sub districts;
• Randomly selected 10 facilities in each district;
• Technical officer and district health officer;
• Clinic committee representative;
• Questionnaire: Quantitative
Qualitative;
• Timeline: February and July 2012;
• Health promoter, operational manager or chairperson completed the questionnaire.
Slide 6
![Page 9: Informing the Capacitation of Clinic Committees in High HIV prevalence Areas](https://reader036.vdocument.in/reader036/viewer/2022062616/549c773cb47959aa318b4723/html5/thumbnails/9.jpg)
Determinants
a. Functionality;
b. Role of clinic committee members;
c. Challenges;
d. Best Practices.
Slide 7
![Page 10: Informing the Capacitation of Clinic Committees in High HIV prevalence Areas](https://reader036.vdocument.in/reader036/viewer/2022062616/549c773cb47959aa318b4723/html5/thumbnails/10.jpg)
Results 1 - Members Slide 10
![Page 11: Informing the Capacitation of Clinic Committees in High HIV prevalence Areas](https://reader036.vdocument.in/reader036/viewer/2022062616/549c773cb47959aa318b4723/html5/thumbnails/11.jpg)
Results 2 – Technical Documents • 22% of the committees did not keep minutes
or any records;
• 39% indicated that they used the DHP as a knowledge management or guidance tool;
• 60% indicated that they were not aware of the IDP;
• In KZN, 100% of the clinic committees interviewed were aware of the IDP and its role and referred to the document during meetings i.e OSS / “war rooms”.
Slide 11
![Page 12: Informing the Capacitation of Clinic Committees in High HIV prevalence Areas](https://reader036.vdocument.in/reader036/viewer/2022062616/549c773cb47959aa318b4723/html5/thumbnails/12.jpg)
Results 3 – PHC Re-engineering
• 43% of the respondents indicated that the clinic committees will play a vital role in the PHC re-engineering process
• Only 17% had members who were currently involved in the PHC re-engineering
Slide 12
43%
17%
play a role
currently involved
![Page 13: Informing the Capacitation of Clinic Committees in High HIV prevalence Areas](https://reader036.vdocument.in/reader036/viewer/2022062616/549c773cb47959aa318b4723/html5/thumbnails/13.jpg)
Results 4 – Governance & Representation
• Governance framework to assist clinic committees
• 56% indicated that there was a framework in place;
• However only 23% had the framework at the facility;
• Representation of the clinic committee at district or municipal level was only indicated by 3 facilities;
• In KZN, respondents referred issues to the war room or to their ward councilors;
• 65% of respondents indicated that there should be strong links with local government but most could not articulate assistance except to action or resolve issues.
Slide 13
![Page 14: Informing the Capacitation of Clinic Committees in High HIV prevalence Areas](https://reader036.vdocument.in/reader036/viewer/2022062616/549c773cb47959aa318b4723/html5/thumbnails/14.jpg)
Results 5 – Challenges • 95% respondents indicated that there were 2
or more challenges experienced
• Challenges:
- Commitment from members;
– Role clarification;
– Providing the community with feedback;
– Which documents to refer to;
– Capacitation on health issues;
– Demotivated members due to unresolved issues;
– Members should be provided with a stipend.
Slide 14
![Page 15: Informing the Capacitation of Clinic Committees in High HIV prevalence Areas](https://reader036.vdocument.in/reader036/viewer/2022062616/549c773cb47959aa318b4723/html5/thumbnails/15.jpg)
Recommendations
• Develop a framework of coordination for HIV
Slide 15
prevention related activities between local political stakeholders, health care workers and the community members.
Community
Municipal
Clinic Committee
Health care workers
![Page 16: Informing the Capacitation of Clinic Committees in High HIV prevalence Areas](https://reader036.vdocument.in/reader036/viewer/2022062616/549c773cb47959aa318b4723/html5/thumbnails/16.jpg)
Recommendations 1
• Coordinate resources geared towards HIV combination prevention services.
“services are provided on different days which would mean patients have to come in more than once”
• Capacitation of members on clinic committee’s and its role in advocating HIV combination prevention activities within communities.
Slide 16
![Page 17: Informing the Capacitation of Clinic Committees in High HIV prevalence Areas](https://reader036.vdocument.in/reader036/viewer/2022062616/549c773cb47959aa318b4723/html5/thumbnails/17.jpg)
Recommendations 2 • Aligning activities to the District Strategic Plan
(DSP) and the needs of the community, using their available resources.
• Capacitating members to monitor implementation of agreed activities as aligned to the DSP.
• Capacitate committee members to develop a framework encapsulating best practices
Slide 17
![Page 18: Informing the Capacitation of Clinic Committees in High HIV prevalence Areas](https://reader036.vdocument.in/reader036/viewer/2022062616/549c773cb47959aa318b4723/html5/thumbnails/18.jpg)
Acknowledgments
• SHIPP would like to acknowledge the contributions of:
*District health officers;
*Clinic committee members and
*USAID
Slide 18
![Page 19: Informing the Capacitation of Clinic Committees in High HIV prevalence Areas](https://reader036.vdocument.in/reader036/viewer/2022062616/549c773cb47959aa318b4723/html5/thumbnails/19.jpg)
Acknowledgements
Slide 19
This presentation is made possible by the support of the American people through the United States Agency for International Development (USAID) and do not necessarily reflect the views of USAID or the United States Government.
![Page 20: Informing the Capacitation of Clinic Committees in High HIV prevalence Areas](https://reader036.vdocument.in/reader036/viewer/2022062616/549c773cb47959aa318b4723/html5/thumbnails/20.jpg)
• For further information on this presentation please contact:
Ravikanthi Rapiti
USAID SHIPP